Trial Outcomes & Findings for New Technologies to Help Manage ADHD (NCT NCT02390791)
NCT ID: NCT02390791
Last Updated: 2019-09-13
Results Overview
the number of days covered with medicine will be calculated from audit of prescriptions written
COMPLETED
NA
85 participants
first 6 months of treatment
2019-09-13
Participant Flow
Participant milestones
| Measure |
Enhanced myADHDportal.Com
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Overall Study
STARTED
|
40
|
45
|
|
Overall Study
COMPLETED
|
40
|
45
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
New Technologies to Help Manage ADHD
Baseline characteristics by cohort
| Measure |
Enhanced myADHDportal.Com
n=40 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=45 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
Total
n=85 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
7.88 years
STANDARD_DEVIATION 1.34 • n=99 Participants
|
7.96 years
STANDARD_DEVIATION 1.23 • n=107 Participants
|
7.92 years
STANDARD_DEVIATION 1.28 • n=206 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=99 Participants
|
11 Participants
n=107 Participants
|
23 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
28 Participants
n=99 Participants
|
34 Participants
n=107 Participants
|
62 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
3 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
8 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
37 Participants
n=99 Participants
|
39 Participants
n=107 Participants
|
76 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
1 Participants
n=107 Participants
|
1 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=99 Participants
|
6 Participants
n=107 Participants
|
13 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
30 Participants
n=99 Participants
|
33 Participants
n=107 Participants
|
63 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=99 Participants
|
3 Participants
n=107 Participants
|
5 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
PRIMARY outcome
Timeframe: first 6 months of treatmentthe number of days covered with medicine will be calculated from audit of prescriptions written
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=40 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=45 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Medication Continuity: The Number of Days Covered With Medicine
|
108.8 Days
Standard Deviation 45.8
|
133.3 Days
Standard Deviation 50.9
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Necessity to concerns differential score, range -4 to 4, positive scores mean necessity outweighs concerns, negative scores mean that concerns outweigh beliefs about necessity
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=24 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Parent-reported Necessity to Concerns Differential (Beliefs About Medication Scale)
|
0.44 score on a scale
Interval -1.18 to 1.11
|
-0.06 score on a scale
Interval -0.52 to 0.86
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Total score calculated from parent-report on the Decisional Conflict Scale, range 0 to 100; higher scores are worse
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=25 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Parent-reported Decisional Conflict (Decisional Conflict Scale)
|
14.06 score on a scale
Interval 6.25 to 29.69
|
20.31 score on a scale
Interval 14.06 to 26.56
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Total score calculated from parent-report on the Trust in Provider Scale, range 10 to 50 with higher scores better (more trust)
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=24 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Parent Trust in Provider (Trust in Provider Scale)
|
45.0 score on a scale
Interval 38.0 to 48.0
|
41.5 score on a scale
Interval 39.0 to 46.5
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
range 12-60, higher scores better (more alliance)
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=24 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Working Alliance Inventory
|
50.0 score on a scale
Interval 44.0 to 55.0
|
46.0 score on a scale
Interval 44.0 to 49.5
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Total score calculated from parent-report on the Perceived Social Support Scale, range 12-84, higher score better (more social support)
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=24 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Parent Perceived Social Support (Perceived Social Support Scale)
|
54.00 score on a scale
Interval 42.0 to 72.0
|
68.95 score on a scale
Interval 44.0 to 72.0
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Parental distress subscale score calculated from the Parenting Stress Index - Short Form; range 36-180, higher scores is worse (more stress)
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=22 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=23 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Parent Distress (Parenting Stress Index - Short Form)
|
75.57 score on a scale
Interval 55.0 to 92.0
|
74.00 score on a scale
Interval 56.0 to 93.0
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentPopulation: population who completed this outcome assessment
Number of Participants with side effects rated by parents as moderate or severe on the Pittsburgh Side Effects Rating Scale
Outcome measures
| Measure |
Enhanced myADHDportal.Com
n=23 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=25 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Number of Participants With Side Effects Rated by Parents as Moderate or Severe on the Pittsburgh Side Effects Rating Scale
|
13 Participants
|
9 Participants
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentOutcome measures
| Measure |
Enhanced myADHDportal.Com
n=40 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=45 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Total Number of myADHDportal.Com Log-ins by Parent
|
11.33 logins
Standard Deviation 13.84
|
8.47 logins
Standard Deviation 7.53
|
SECONDARY outcome
Timeframe: 6 months after starting treatmentOutcome measures
| Measure |
Enhanced myADHDportal.Com
n=40 Participants
Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
enhanced myADHDportal.com: Version of the myADHDportal.com web software enhanced with family-management support to enable parents to be active partners in optimizing and maintaining medication continuity for their child
|
Treatment as Usual Standard Portal
n=45 Participants
Standard version of myADHDportal.com web software
treatment as usual standard portal: Standard version of myADHDportal.com web software
|
|---|---|---|
|
Total Number of Measures Completed by Parents to Track Child Response to Treatment
|
2.50 measures
Standard Deviation 3.37
|
2.31 measures
Standard Deviation 3.00
|
Adverse Events
Enhanced myADHDportal.Com
Treatment as Usual Standard Portal
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place